两癌筛查系统的创新实践

技术赋能的三大变革：

The three major changes empowered by technology:

智能筛查设备升级：

Upgrade of intelligent screening equipment:

新型 AI 乳腺超声设备（如联影 uAI-Breast）通过三维重建技术，将乳腺结节检出率提升至 98.7%，较传统超声提高 12%。

The new AI breast ultrasound equipment (such as the United Imaging uAI Breast) has increased the detection rate of breast nodules to 98.7% through 3D reconstruction technology, which is 12% higher than traditional ultrasound.

宫颈癌筛查领域，华大基因的 HPV 检测试剂盒实现 28 种高危型分型，灵敏度达 99.6%，较传统方法缩短检测时间至 4 小时。

In the field of cervical cancer screening, BGI Genomics' HPV testing kit achieves typing of 28 high-risk types with a sensitivity of 99.6%, shortening the detection time to 4 hours compared to traditional methods.

数据驱动的精准防控：

Data driven precision prevention and control:

国家癌症中心构建的 “两癌筛查大数据平台” 整合全国 2.3 亿份筛查数据，通过机器学习建立风险预测模型，将乳腺癌风险评估准确率提升至 89%，宫颈癌风险预警提前量达 3 年。

The "Big Data Platform for Two Cancer Screening" built by the National Cancer Center integrates 230 million screening data across the country, builds a risk prediction model through machine learning, improves the accuracy of breast cancer risk assessment to 89%, and advances cervical cancer risk early warning by three years.

上海、深圳等地试点 “AI 辅助诊断云平台”，基层医院将宫颈细胞涂片上传云端，AI 系统 5 分钟内生成诊断报告，基层诊断符合率从 65% 提升至 92%。

Shanghai, Shenzhen and other places are piloting the "AI assisted diagnosis cloud platform". Primary hospitals upload cervical cell smears to the cloud, and the AI system generates diagnostic reports within 5 minutes. The primary diagnosis compliance rate has increased from 65% to 92%.

服务模式创新：

Service model innovation:

广西恭城县推行 “一站式筛查服务”，将原本分散在 5 个科室的流程整合为 “登记 - 采样 - 检查 - 报告” 四步，筛查效率提升 3 倍。

Gongcheng County in Guangxi Province has implemented a "one-stop screening service", integrating the previously scattered process of five departments into four steps of "registration sampling inspection reporting", which has increased screening efficiency by three times.

福州仓山区开发 “两癌筛查小程序”，实现线上预约、结果查询、随访提醒全流程数字化，患者满意度达 95%。

Fuzhou Cangshan District has developed a "two cancer screening mini program" to digitize the entire process of online appointment, result query, and follow-up reminder, with a patient satisfaction rate of 95%.

未来图景：从 “疾病筛查” 到 “健康管理”

Future vision: from "disease screening" to "health management"

1. 多癌种联合筛查：

1. Multi cancer combined screening:

国家癌症中心启动 “泛癌早筛计划”，通过血液检测同时筛查宫颈癌、乳腺癌、肺癌等 8 种癌症，2025 年试点数据显示，早期癌症检出率提升至 65%。

The National Cancer Center launched the "pan cancer early screening program" to screen eight cancers, including cervical cancer, breast cancer and lung cancer, through blood testing. The pilot data in 2025 shows that the detection rate of early cancer has increased to 65%.

2. 个性化健康干预：

2. Personalized health intervention:

阿里健康开发 “女性健康数字孪生系统”，通过分析遗传、生活方式、环境等数据，为每位女性生成个性化筛查方案。例如，对携带 BRCA1 突变的女性，系统建议从 25 岁开始每年进行乳腺 MRI 检查。

Alibaba Health has developed the 'Women's Health Digital Twin System', which generates personalized screening plans for each woman by analyzing genetic, lifestyle, environmental, and other data. For example, for women carrying BRCA1 mutations, the system recommends annual breast MRI examinations starting from the age of 25.

3. 医疗资源下沉：

3. Sinking of medical resources:

华为云联合基层医院部署 “5G+AI 筛查站”，通过远程超声机器人和 AI 诊断系统，使偏远地区患者可享受三甲医院级筛查服务。2025 年试点区域筛查覆盖率提升至 95%，阳性病例漏诊率下降至 0.8%。

Huawei Cloud collaborates with grassroots hospitals to deploy "5G+AI screening stations", which enable remote patients to enjoy tertiary hospital level screening services through remote ultrasound robots and AI diagnostic systems. By 2025, the screening coverage rate in pilot areas will be increased to 95%, and the missed diagnosis rate of positive cases will be reduced to 0.8%.

中国两癌筛查系统的进化史，是一部科技赋能公共卫生的生动实践。从 AI 辅助诊断到区块链数据安全，从云端病理会诊到 5G 远程筛查，这些创新不仅提升了筛查效率，更重塑了医疗公平的边界。当技术红利真正惠及每一位女性，我们正在书写的，不仅是疾病防控的新篇章，更是健康中国战略最温暖的注脚

The evolutionary history of China's two cancer screening systems is a vivid practice of technology empowering public health. From AI assisted diagnosis to blockchain data security, from cloud based pathology consultation to 5G remote screening, these innovations not only improve screening efficiency, but also reshape the boundaries of medical fairness. When the technological dividend truly benefits every woman, what we are writing is not only a new chapter in disease prevention and control, but also the warmest footnote to the Healthy China strategy

本文由两癌筛查系统友情奉献.更多有关的知识请点击:http://www.guantangyiliao.com我们将会对您提出的疑问进行详细的解答，欢迎您登录网站留言.

This article is dedicated to friendship For more information, please click: We will provide detailed answers to your questions. You are welcome to log in to our website and leave a message